Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surrogate Markers of Portal Pressure in Compensated Cirrhosis Undergoing Anti-viral Therapy
NCT02508298Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of indocyanine green in Cirrhosis and Portal Hypertension (PH) (3 arms), sponsored by United States Department of Veterans Affairs. Primary endpoint: Indocyanine Green before and after treatment of hepatitis c at 2 years. Started Apr 2014; status: completed.
02
Drugs
indocyanine green
03
Conditions
CirrhosisPortal Hypertension (PH)
Beyond the preview
Go deeper on NCT02508298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508298.